Logo 1 Logo 2

Clinical Trial Details

Trial ID: L3104
Source ID: NCT00104182
Associated Drug: Insulin Detemir
Title: Comparison of Insulin Detemir Morning, Insulin Detemir Evening and NPH Insulin Evening in Patients With Type 2 Diabetes
Acronym:
Status: COMPLETED
Study Results: NO
Results:
Conditions: Diabetes|Diabetes Mellitus, Type 2
Interventions: DRUG: insulin detemir|DRUG: insulin NPH
Outcome Measures: Primary: HbA1C, after 20 weeks | Secondary: Adverse events|body weight|Hypoglycemia|Blood glucose
Sponsor/Collaborators: Sponsor: Novo Nordisk A/S
Gender: ALL
Age: ADULT, OLDER_ADULT
Phases: PHASE3
Enrollment: 503
Study Type: INTERVENTIONAL
Study Designs: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Start Date: 2005-02
Completion Date: 2006-02
Results First Posted:
Last Update Posted: 2017-01-30
Locations: Novo Nordisk Investigational Site, Birmingham, Alabama, 35235, United States|Novo Nordisk Investigational Site, Mesa, Arizona, 85205, United States|Novo Nordisk Investigational Site, Phoenix, Arizona, 85029, United States|Novo Nordisk Investigational Site, Anaheim, California, 92801, United States|Novo Nordisk Investigational Site, Concord, California, 94520, United States|Novo Nordisk Investigational Site, Fullerton, California, 92835, United States|Novo Nordisk Investigational Site, La Jolla, California, 92037, United States|Novo Nordisk Investigational Site, Los Angeles, California, 90057, United States|Novo Nordisk Investigational Site, Orange, California, 92869, United States|Novo Nordisk Investigational Site, Poway, California, 92064, United States|Novo Nordisk Investigational Site, Denver, Colorado, 80220, United States|Novo Nordisk Investigational Site, Lake Mary, Florida, 32746, United States|Novo Nordisk Investigational Site, Springfield, Illinois, 62711, United States|Novo Nordisk Investigational Site, Fall River, Massachusetts, 02721, United States|Novo Nordisk Investigational Site, Waltham, Massachusetts, 02453, United States|Novo Nordisk Investigational Site, Jefferson City, Missouri, 65109, United States|Novo Nordisk Investigational Site, Las Vegas, Nevada, 89030, United States|Novo Nordisk Investigational Site, Lewiston, New York, 14092, United States|Novo Nordisk Investigational Site, Williamsville, New York, 14221, United States|Novo Nordisk Investigational Site, Grand Forks, North Dakota, 58201, United States|Novo Nordisk Investigational Site, Cincinnati, Ohio, 45291, United States|Novo Nordisk Investigational Site, Dayton, Ohio, 45406, United States|Novo Nordisk Investigational Site, Connellsville, Pennsylvania, 15425, United States|Novo Nordisk Investigational Site, Lancaster, Pennsylvania, 17601, United States|Novo Nordisk Investigational Site, Norristown, Pennsylvania, 19401, United States|Novo Nordisk Investigational Site, Greer, South Carolina, 29651, United States|Novo Nordisk Investigational Site, Conroe, Texas, 77384, United States|Novo Nordisk Investigational Site, Killeen, Texas, 76543, United States|Novo Nordisk Investigational Site, Seattle, Washington, 98105, United States|Novo Nordisk Investigational Site, Aalborg, 9000, Denmark|Novo Nordisk Investigational Site, Esbjerg, 6700, Denmark|Novo Nordisk Investigational Site, Glostrup, 2600, Denmark|Novo Nordisk Investigational Site, Herlev, 2730, Denmark|Novo Nordisk Investigational Site, Hillerød, 3400, Denmark|Novo Nordisk Investigational Site, Hjørring, 9800, Denmark|Novo Nordisk Investigational Site, Horsens, 8700, Denmark|Novo Nordisk Investigational Site, Hvidovre, 2650, Denmark|Novo Nordisk Investigational Site, København S, 2300, Denmark|Novo Nordisk Investigational Site, København, 2400, Denmark|Novo Nordisk Investigational Site, Næstved, 4700, Denmark|Novo Nordisk Investigational Site, Roskilde, 4000, Denmark|Novo Nordisk Investigational Site, Bagnols-sur-ceze, 30200, France|Novo Nordisk Investigational Site, Besancon, 25030, France|Novo Nordisk Investigational Site, Carcassonne, 11000, France|Novo Nordisk Investigational Site, Corbeil Essonnes, 91106, France|Novo Nordisk Investigational Site, DAX, 40107, France|Novo Nordisk Investigational Site, MONTPELLIER cedex 5, 34295, France|Novo Nordisk Investigational Site, Quimper, 29107, France|Novo Nordisk Investigational Site, Rueil-malmaison, 92501, France|Novo Nordisk Investigational Site, Tours, 37044, France|Novo Nordisk Investigational Site, Venissieux, 69200, France|Novo Nordisk Investigational Site, Cagliari, 09134, Italy|Novo Nordisk Investigational Site, Catania, 95126, Italy|Novo Nordisk Investigational Site, Genova, 16132, Italy|Novo Nordisk Investigational Site, Messina, 98123, Italy|Novo Nordisk Investigational Site, Monza, 20052, Italy|Novo Nordisk Investigational Site, Napoli, 80131, Italy|Novo Nordisk Investigational Site, Parma, 43100, Italy|Novo Nordisk Investigational Site, Pescara, 65124, Italy|Novo Nordisk Investigational Site, Prato, 59100, Italy|Novo Nordisk Investigational Site, Roma, 00161, Italy|Novo Nordisk Investigational Site, Torino, 10126, Italy|Novo Nordisk Investigational Site, Treviso, 31100, Italy|Novo Nordisk Investigational Site, Almelo, 7609 PP, Netherlands|Novo Nordisk Investigational Site, Den Bosch, 5216 GC, Netherlands|Novo Nordisk Investigational Site, Den Haag, 2584 HV, Netherlands|Novo Nordisk Investigational Site, Etten-Leur, 4872 LP, Netherlands|Novo Nordisk Investigational Site, Roelofarendsveen, 2371 RB, Netherlands|Novo Nordisk Investigational Site, Rotterdam, 3082 DC, Netherlands|Novo Nordisk Investigational Site, Vlodrop, 6063 DA, Netherlands|Novo Nordisk Investigational Site, Bergen, 5021, Norway|Novo Nordisk Investigational Site, Bergen, NO-5012, Norway|Novo Nordisk Investigational Site, Elverum, 2408, Norway|Novo Nordisk Investigational Site, Gjøvik, NO-2819, Norway|Novo Nordisk Investigational Site, Kongsvinger, 2212, Norway|Novo Nordisk Investigational Site, Oslo, 0370, Norway|Novo Nordisk Investigational Site, Oslo, 0586, Norway|Novo Nordisk Investigational Site, Stavanger, 4011, Norway|Novo Nordisk Investigational Site, Trondheim, NO-7030, Norway|Novo Nordisk Investigational Site, Alcorcón, 28922, Spain|Novo Nordisk Investigational Site, Almería, 04009, Spain|Novo Nordisk Investigational Site, Barcelona, 08017, Spain|Novo Nordisk Investigational Site, Barcelona, 08025, Spain|Novo Nordisk Investigational Site, Barcelona, 08035, Spain|Novo Nordisk Investigational Site, Bilbao, 48013, Spain|Novo Nordisk Investigational Site, Cádiz, 11009, Spain|Novo Nordisk Investigational Site, Getafe, 28905, Spain|Novo Nordisk Investigational Site, Gijón, 33206, Spain|Novo Nordisk Investigational Site, Granada, 18012, Spain|Novo Nordisk Investigational Site, Palma de Mallorca, 07198, Spain|Novo Nordisk Investigational Site, Pamplona, 31008, Spain|Novo Nordisk Investigational Site, Santa Cruz de Tenerife, 38010, Spain|Novo Nordisk Investigational Site, Santiago de Compostela, 15706, Spain|Novo Nordisk Investigational Site, Valencia, 46026, Spain|Novo Nordisk Investigational Site, Valladolid, 47010, Spain|Novo Nordisk Investigational Site, Valladolid, 47011, Spain
URL: https://clinicaltrials.gov/show/NCT00104182

Drug ID Drug Name Type DrugBank ID Targets Category Latest Progress